Back to search
Lupus Nephritis - WHO Class III
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Lupus Nephritis - WHO Class III trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Lupus Nephritis - WHO Class III trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The primary objective of this trial is to evaluate the efficacy and safety of FT819, comprised of allogeneic T cells that express a CD19-targeted CAR, following…
AB-101 (also known as AlloNK) is an off-the shelf, allogeneic cell product made of "natural killer" cells, also called NK cells. White blood cells are part of t…